Page "Pharmacia" Paragraph 3

Dextran-based products were to play a significant role in the further expansion of Pharmacia.

In 1951, the company moved to Uppsala, Sweden, to get closer to the scientists with whom they cooperated, and Ingelman became its head of research.

In 1959, Pharmacia pioneered gel filtration with its Sephadex products.

These were also based on dextran and discoveries in Tiselius ' department, this time by Jerker Porath and Per Flodin.

In 1967 Pharmacia Fine Chemicals was established in Uppsala.

In 1986 Pharmacia Fine Chemicals acquired LKB-produkter AB and changed name to Pharmacia Biotech.

Pharmacia Biotech expanded there role in the ' biotech revolution ' through its acquisition of PL Laboratories from Pabst Brewery offering a line of recombinant DNA specialty research chemicals.

Sold to private interests in the 1990s, Pharmacia was first merged with " Kabi Vitrum " to form Kabi Pharmacia with headquarters in Uppsala.

Kabi was later excluded.

Then the company merged with the American pharmaceutical company Upjohn in 1995 and moved its headquarters to London.